书信:创伤后免疫抑制

Same author

Diagnostic and therapeutic considerations for "mycotic" cerebral aneurysms: 2 case reports and review of the literature.

Central European neurosurgery·2011

Same author

Site distribution of oesophagogastric cancer.

Journal of clinical pathology·2002

Same author

A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease.

Journal of immunology (Baltimore, Md. : 1950)·2001

Same author

Argon beam plasma coagulation in the management of cancers of the esophagus and stomach.

Surgical endoscopy·2001

Same author

Symptomatic mediastinal lymphatic cyst after esophagectomy.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2000

Same author

Palliation in oesophageal neoplasia.

Annals of the Royal College of Surgeons of England·2000

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

书信:创伤后免疫抑制

相关概念视频

Diagnostic and therapeutic considerations for "mycotic" cerebral aneurysms: 2 case reports and review of the literature.

Site distribution of oesophagogastric cancer.

A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease.

Argon beam plasma coagulation in the management of cancers of the esophagus and stomach.

Symptomatic mediastinal lymphatic cyst after esophagectomy.

Palliation in oesophageal neoplasia.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

书信:创伤后免疫抑制

相关概念视频

相关文章

Diagnostic and therapeutic considerations for "mycotic" cerebral aneurysms: 2 case reports and review of the literature.

Site distribution of oesophagogastric cancer.

A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease.

Argon beam plasma coagulation in the management of cancers of the esophagus and stomach.

Symptomatic mediastinal lymphatic cyst after esophagectomy.

Palliation in oesophageal neoplasia.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.